Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease. (2022)
Attributed to:
Treating the host in Dengue: mediators and pathways of resolution as a new therapeutic paradigm
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.73853
PubMed Identifier: 35293862
Publication URI: http://europepmc.org/abstract/MED/35293862
Type: Journal Article/Review
Volume: 11
Parent Publication: eLife
ISSN: 2050-084X